Fast-track cardiac anesthesia in patients with sickle cell abnormalities

Anesthesia and Analgesia

Volumn 89, Issue 3, 1999, Pages 598-603

  Djaiani, George N ^a   Cheng, Davy C H ^a   Carroll, Jo A ^a   Yudin, Mark ^a   Karski, Jacek M ^a  

^a UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANESTHESIA; ARTICLE; BLOOD TRANSFUSION; CONTROLLED STUDY; EXTUBATION; FEMALE; HEMATOCRIT; HEMOGLOBIN DETERMINATION; HOSPITALIZATION; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; MALE; POSTOPERATIVE HEMORRHAGE; PRACTICE GUIDELINE; PRIORITY JOURNAL; SICKLE CELL TRAIT;

ADULT; ANESTHESIA; BLOOD LOSS, SURGICAL; BLOOD PRESSURE; CARDIAC SURGICAL PROCEDURES; CARDIOPULMONARY BYPASS; CORONARY ARTERY BYPASS; FEMALE; HEART ARREST, INDUCED; HEART RATE; HEMOGLOBINS; HUMANS; INTRAOPERATIVE PERIOD; MALE; MIDDLE AGED; POSTOPERATIVE PERIOD; RETROSPECTIVE STUDIES; SICKLE CELL TRAIT;

EID: 0032871263     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000539-199909000-00010     Document Type: Article

References (30)

1. Holzman L, Finn H, Lichtman HC, Harmel MH. Anesthesia in patients with sickle cell disease: a review of 112 cases. Anesth Analg 1969;48:566-72.
2. Koshy M, Weiner SJ, Miller ST, et al. Surgery and anesthesia in sickle cell disease. Blood 1995;86:3676-84.
3. Cheng DCH, Karski J, Peniston C, et al. Morbidity outcome in early versus conventional tracheal extubation after coronary artery bypass grafting: a prospective randomized controlled trial. J Thorac Cardiovasc Surg 1996;112:755-64.
4. Cheng DCH, Karski J, Peniston C, et al. Early tracheal extubation after coronary artery bypass graft surgery reduces costs and improves resource use. Anesthesiology 1996;85:1300-10.
5. 2 [letter]. J Cardiothorac Vase Anesth 1992;6:514.
6. Fox MA, Abbott TR. Hypothermic cardiopulmonary bypass in a patient with sickle-cell trait. Anaesthesia 1984;39:1121-3.
7. Riethmuller R, Grundy EM, Radley-Smith R. Open heart surgery in a patient with homozygos sickle cell disease. Anaesthesia 1982;37:324-7.
8. Hudson I, Davidson IA, McGregor CGA. Mitral valve replacement using cold cardioplegia in a patient with sickle cell trait. Thorax 1981;36:151-2.
9. Bomfim V, Ribeiro A, Gouvea F, et al. Sickle cell anemia and mitral valve replacement. Scand J Thor Cardiovasc Surg 1989; 23:75-7.
10. McGovern E, Otridge BW, Neligan MC. Mitral valve replacement in a patient with sickle cell anaemia. Thorac Cardiovasc Surg 1987;35:129-30.
11. Kingsley SP, Chronister T, Cohen DJ, et al. Anesthetic management of a patient with hemoglobin SS disease and mitral insufficiency for mitral valve repair. J Cardiothorac Vasc Anesth 1996;10:419-24.
12. Metras D, Quezzin-Coulibaly A, Ouattara K, et al. Open-surgery in sickle-cell haemoglobinopathies: report of 15 cases. Thorax 1982;37:486-91.
13. Balasundaram S, Duran CG, Al-Halees Z, Kassay M. Cardiopulmonary bypass in sickle cell anemia: report of five cases. J Cardiovasc Surg 1991;32:271-4.
14. Sivapragasam S, Shah S, Chatoorgoon A. Open heart surgery in patients with sickle haemoglobin, 1968-1978. West Indian Med J 1980;29:336-41.
15. Ivanov J, Weisel RD, David TE, Naylor CD. Fifteen-year trends in risk severity and operative mortality in elderly patients undergoing coronary artery bypass graft surgery. Circulation 1998; 97:673-80.
16. Arom KV, Emery RW, Petersen RJ, Schwartz M. Cost-effectiveness and predictors of early extubation. Ann Thorac Surg 1995;60:127-32.
17. Higgins TL. Quantifying risk and assessing outcome in cardiac surgery. J Cardiothorac Vase Anesth 1998;12:330-40.
18. Esseltine DW, Baxter MRN, Bevan JC. Sickle cell states and the anaesthetist. Can J Anaesth 1988;35:385-403.
19. Pagani FD, Polito RJ, Bolling SF. Mitral valve reconstruction in sickle cell disease. Ann Thorac Surg 1996;61:1841-3.
20. Shulman G, McQuitty C, Vertrees RA, Conti VR. Acute normovolemic red cell exchange for cardiopulmonary bypass in sickle cell disease. Ann Thorac Surg 1998;65:1444-6.
21. Howells TH, Huntsman RG, Boys JE, Mahmood A. Anaesthesia and sickle-cell haemoglobin. Br J Anaesth 1972;44:975-87.
22. Vichinsky EP, Haberkern CM, Neumayr L, et al. The Perioperative Transfusion in Sickle Cell Disease Study Group. A comparison of conservative and aggressive transfusion regimens in the perioperative management of sickle cell disease. N Engl J Med 1995;333:206-13.
23. Heiner M, Teasdale SJ, David T, et al. Aorto-coronary bypass in a patient with sickle cell trait. Can Anaesth Soc J 1979;26:428-34.
24. Wenham PW, Scott GL, Wisheart JD. Red cell survival after aortic valve replacement with Björk-Shiley prosthesis in presence of sickle cell trait. Br Heart J 1978;40:703-4.
25. Somanathan S. Anaesthesia and hypothermia in sickle cell disease [letter]. Anaesthesia 1976;31:113.
26. Cosgrove DM, Loop FD, Lytle BW, et al. Determinants of blood utilization during myocardial revascularization. Ann Thorac Surg 1985;40:380-4.
27. Mathieu M, Karski J, Cheng DCH, et al. Preoperative anemia in patients undergoing heart surgery: etiology and implications on perioperative blood transfusion [abstract]. Anesth Analg 1997; 84:SCA120.
28. Stafford Smith M, Conlon PJ, White WD, et al. Low hematocrit but not perfusion pressure during CPB is predictive for renal failure following CABG surgery [abstract]. Anesth Analg 1998; 86:SCA102.
29. Varvitsiotis PS, Jones JW, Nahas C, Beali AC. Myocardial revascularization in a sickle-cell trait patient. Cardiovasc Surg 1995; 3:603-4.
30. Bellet PS, Kalinyak KAR, Gelfand MJ, Ruckagel DL. Incentive spirometry to prevent acute pulmonary complications in sickle cell diseases. N Engl J Med 1995;333:699-703.